However, trofosfamide and sirolimus showed a trend towards being more efficacious in PF-A tumors with or without chromosome 1q-gain, respectively.
← all excerpts
Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies.
1
—
—